Michael J. Pederson - 28 Feb 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Mar 2023, 18:49:27 UTC
Prior SEC filing
02 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael J. Pederson by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Michael J. Pederson filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 Mar 2023.

Key facts

  • This page summarizes Michael J. Pederson's Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2023, 18:49.

Change

  • Previous filing in this sequence was filed on 02 Mar 2022.
  • Current net transaction value: -$351,390.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Tax liability

Transaction value
$351,390
Shares
-3,522
Change %
-5.3%
Price
$99.77
Shares after
63,156
Date
28 Feb 2023
Ownership
Direct
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
75
Date
28 Feb 2023
Ownership
By Spouse
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .